Ohuchi N, Mori S
Second Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.
Gan To Kagaku Ryoho. 1991 Jan;18(1):30-6.
Several methods for DNA analysis including DNA histogram and proto-oncogene amplification in human breast cancer, and the results recently reported were reviewed. A large number of DNA histograms obtained by flow cytometry have provided a possible correlation between DNA ploidy pattern and clinical outcome of breast cancer patients. Poor clinicopathologic factors, however, are not always in association with DNA aneuploidy and/or S-phase fraction rate, suggesting that further investigations on DNA ploidy are required. Amplification and/or over expression of proto-oncogenes in human breast cancers have been reported. Among them c-erbB-2 amplification may be one of the candidates for prognostic indicators of breast cancer survival. To determine any reliable biological factors exist further analysis of tumor DNA will be required in breast cancer research.
综述了几种用于人类乳腺癌DNA分析的方法,包括DNA直方图和原癌基因扩增,以及最近报道的结果。通过流式细胞术获得的大量DNA直方图揭示了DNA倍体模式与乳腺癌患者临床结局之间可能存在的关联。然而,不良的临床病理因素并不总是与DNA非整倍体和/或S期分数率相关,这表明需要对DNA倍体进行进一步研究。已有报道称人类乳腺癌中原癌基因存在扩增和/或过表达。其中,c-erbB-2扩增可能是乳腺癌生存预后指标的候选之一。为了确定是否存在任何可靠的生物学因素,乳腺癌研究需要对肿瘤DNA进行进一步分析。